Mark White
Corporate Officer/Principal en ROCKET PHARMACEUTICALS, INC. .
Fortuna: 2 M $ al 30/04/2024
Perfil
Mark White is currently a Member at The Royal College of Physicians and a Member at the Faculty of Pharmaceutical Medicine.
He is also the General Manager-Commercial Affairs at Rocket Pharmaceuticals, Inc. Mark's former position was as the Global Franchise Head-Fasenra at AstraZeneca PLC.
He completed his undergraduate degree at The University of Manchester.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 08/04/2024 | 75 226 ( 0.08% ) | 2 M $ | 30/04/2024 |
Cargos activos de Mark White
| Empresas | Cargo | Inicio |
|---|---|---|
| ROCKET PHARMACEUTICALS, INC. | Corporate Officer/Principal | 26/03/2024 |
| The Royal College of Physicians | Corporate Officer/Principal | - |
| Faculty of Pharmaceutical Medicine | Corporate Officer/Principal | - |
Antiguos cargos conocidos de Mark White.
| Empresas | Cargo | Fin |
|---|---|---|
| ASTRAZENECA PLC | Corporate Officer/Principal | 01/04/2023 |
Formación de Mark White.
| The University of Manchester | Undergraduate Degree |
Experiencias
Funciones ocupadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| ROCKET PHARMACEUTICALS, INC. | Health Technology |
| ASTRAZENECA PLC | Health Technology |
| Empresas privadas | 1 |
|---|---|
| Faculty of Pharmaceutical Medicine |
- Bolsa de valores
- Insiders
- Mark White
